Clinical Trial Update: One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy

View source ↗

Summary

A clinical trial update reporting the one-year recurrence-free survival among melanoma patients eligible for sentinel lymph node biopsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Melanoma, Skin, Adjuvant Treatment | Status: ACTIVE_NOT_RECRUITING